Editor-in-Chief
Guido Kroemer
University of Paris Descartes, Paris, FR
Laurence Zitvogel
INSERM, Institut Gustave Roussy, Villejuif, FR
Editorial Board
- Jean-Pierre Abastado
- Matthew Albert
- James P. Allison
- Ron N. Apte
- Maha Ayyoub
- Thomas Blankenstein
- Jean-Yves Blay
- Lisa H. Butterfield
- Anne Caignard
- Xuetao Cao
- Chiara Castelli
- Federica Cavallo
- Lieping Chen
- Aled Clayton
- Mario Colombo
- George Coukos
- Pierre Coulie
- Chen Dong
- Glenn Dranoff
- Alexander Eggermont
- Dean Felsher
- Olivera J. Finn
- Bernard A. Fox
- Wolf-Hervé Fridman
- Dmitry I. Gabrilovich
- Thomas F. Gajewski
- Ellie Gilboa
- Axel Hoos
- Anne Hosmalin
- Elizabeth M. Jaffee
- Pawel Kalinski
- Klas Kärre
- Rolf Kiessling
- Eva Klein
- Oliver Lantz
- Roland Liblau
- Michael T. Lotze
- Francesco Marincola
- Carlos Martinez-A
- Ignacio Melero
- Cornelis J. Melief
- Ira Mellman
- Lorenzo Moretta
- Sergei A. Nedospasov
- Hideho Okada
- Anna Karolina Palucka
- Giorgio Parmiani
- Angel Porgador
- George Prendergast
- Gabriel A. Rabinovich
- David H. Raulet
- Caetano Reis e Sousa
- Nick Restifo
- Paola Ricciardi-Castagnoli
- Bruce Robinson
- Pedro Romero
- Dolores J. Schendel
- Jeffrey Schlom
- Hans Schreiber
- Robert Schreiber
- Gerold Schuler
- Ton Schumacher
- Bruno Silva-Santos
- Mark J. Smyth
- Tadatsugu Taniguchi
- Alain Trautmann
- Giorgio Trinchieri
- Danila Valmori
- Benoît Van den Eynde
- Pierre Van der Bruggen
- Richard Vile
- Eric Vivier
- Hermann Wagner
- Theresa L Whiteside
- Ottmar D. Wiestler
- Weiping Zou
Call for Papers
Tumor immunology deals with the natural or therapy-induced recognition of cancers, as well as with the intricate interplay between oncogenesis, inflammation and immunosurveillance. We now introduce a new, high-profile journal, OncoImmunology, that specifically deals with tumor immunology.
OncoImmunology will accept submission in the fundamental translational and clinical areas of tumor immunology. Submissions dealing with solid or hematological cancers. Submissions dealing with solid or hematological cancers, inflammation, innate and acquired immune responses will also be welcome.
OncoImmunology will publish Original Research, Brief Reports, Reviews, Commentaries and Meeting Reports.
Click here for our author guidelines.
Submit your manuscript online:
http://oncoimm.msubmit.net/cgi-bin/main.plex
Questions? Email the Managing Editor, Daniel Olasky
• The Editors undertake to review each manuscript within 30 days of submission.
• Page and color charges are waived for the first year of publication and the final version of accepted manuscripts will be posted on the website promptly.
• Any content posted on the website from now until January 2013 will always be free. Authors will receive a free print version of the issue containing their paper.
